217
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Screening of bioactive compounds from selected mushroom species against putative drug targets in Mycobacterium tuberculosis: a multi-target approach

, , , , , , , & show all
Received 31 Jul 2023, Accepted 20 Mar 2024, Published online: 19 Jun 2024

References

  • Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local alignment search Tool 2 department of computer science. Journal of Molecular Biology, 215(3), 403–410. https://doi.org/10.1006/jmbi.1990.9999
  • Amere, G. A., Nayak, P., Salindri, A. D., Narayan, K. M. V., & Magee, M. J. (2018). Original contribution contribution of smoking to tuberculosis incidence and mortality in high- tuberculosis-burden countries. American Journal of Epidemiology, 187(9), 1846–1855. https://doi.org/10.1093/aje/kwy081
  • Babu, D. R., & Rao, G. N. (2013). Antioxidant properties and electrochemical behavior of cultivated commercial Indian edible mushrooms. Journal of Food Science and Technology, 50, 301–308.
  • Bach, F., Zielinski, A. A. F., Helm, C. V., Maciel, G. M., Pedro, A. C., Stafussa, A. P., Ávila, S., & Haminiuk, C. W. I. (2019). Bio compounds of edible mushrooms : In vitro antioxidant and antimicrobial activities. LWT - Food Science Technol, 107, 214–220. https://doi.org/10.1016/j.lwt.2019.03.017
  • Bauer, M. R., & Mackey, M. D. (2019). Electrostatic complementarity as a fast and effective tool to optimize binding and selectivity of protein–ligand complexes. Journal of Medicinal Chemistry, 62(6), 3036–3050. https://doi.org/10.1021/acs.jmedchem.8b01925
  • Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
  • Bowie, J. U., Lüthy, R., & Eisenberg, D. (1990). A method to identify protein sequences that fold into a known three-dimensional stucture. Science (New York, N.Y.), 253(5016), 164–170. https://doi.org/10.1126/science.1853201
  • Cheeseright, T., Mackey, M., Rose, S., & Vinter, A. (2006). Molecular field extrema as descriptors of biological activity : Definition and validation. Journal of Chemical Information and Modeling, 46(2), 665–676. https://doi.org/10.1021/ci050357s
  • Colovos, C., & Yeates, T. (1993). Verification of protein structures : Patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
  • Dave, A. M., Adelrahman, A., Mehta, V., Cavalieri, S., & Vivekanadan, R. (2017). Verification of diagnosis in tuberculosis: A case report and discussion case presentation. Cureus, 9(9), e1650. https://doi.org/10.7759/cureus.1650
  • De Almeida, I. N. (2019). Frequency of the Mycobacterium tuberculosis RD Rio genotype and its association with multidrug-resistant tuberculosis. BMC Infectious Diseases, 19, 556.
  • Duarte, R. C. R., Lönnroth, K., Carvalho, C., Lima, F., Carvalho, A. C. C., & Mu˜noz-Torrico, M. (2017). Tuberculosis, social determinants and co-morbidities (including HIV). Pneumologia, 24(2), 115–119.
  • Gbylik-Sikorska, M., Gajda, A., Nowacka-Kozak, E., & Posyniak, A. (2018). Simultaneous determination of 45 antibacterial compounds in mushrooms - Agaricus bisporus by ultra-high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography, 1587, 111–118.
  • Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999). A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery: a qualitative and quantitative characterization of known drug databases. Journal of Combinatorial Chemistry, 1(1), 55–68. https://doi.org/10.1021/cc9800071
  • Gupta, S., Summuna, B., Gupta, M., & Annepu S. K. (2018). Edible mushrooms: Cultivation, bioactive molecules, and health benefits. Bioactive Molecules Foods, 1, 1–33. https://doi.org/10.1007/978-3-319-54528-8_86-1
  • Huerta-Cepas, J., Serra, F., & Bork, P. (2016). ETE 3 : Reconstruction, analysis, and visualization of phylogenomic data brief communication. Molecular Biology and Evolution, 33(6), 1635–1638. https://doi.org/10.1093/molbev/msw046
  • Källberg, M., Wang, H., Wang, S., Peng, J., Wang, Z., Lu, H., & Xu, J. (2012). Template-based protein structure modeling using the RaptorX web server. Nature Protocols, 7(8), 1511–1522. https://doi.org/10.1038/nprot.2012.085
  • Kanehisa, M., Goto, S., Furumichi, M., & Tanabe, M. (2010). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acid Research 38, 355–360.
  • Kawasaki, M., Echiverri, C., Raymond, L., Cadena, E., Reside, E., Gler, M. T., Oda, T., Ito, R., Higashiyama, R., Katsuragi, K., & Liu, Y. (2019). Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts. PLoS Medicine, 16(4), e1002780. https://doi.org/10.1371/journal.pmed.1002780
  • Kihisa, T. A., Ranzblau, G. F., Okuda, H. T., Agata, M. T., Uzuki, T. S., & Asukawa, K. Y. (2005). Antitubercular activity and inhibitory effect on Epstein-Barr virus activation of sterols and polyisoprenepolyols from an edible mushroom, Hypsizigus marmoreus. Biological and Pharmaceutical Bulletin, 28(6), 1117–1119.
  • Kim, S. (2019). PubChem 2019 update : Improved access to chemical data. Nucleic Acids Research, 47, 1102–1109.
  • Kuhn, M., Firth-Clark, S., Tosco, P., Mey, A. S. J. S., Mackey, M. D., & Michel, J. (2020). Assessment of binding affinity via alchemical free energy calculations. Journal of Chemical Information and Modeling, 60(6), 3120–3130. https://doi.org/10.1021/acs.jcim.0c00165
  • Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., & Thornton, J. M. (1996). AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR, 8(4), 477–486. https://doi.org/10.1007/BF00228148
  • Li, Z., Jaroszewski, L., Iyer, M., Sedova, M., & Godzik, A. (2020). FATCAT 2.0: Towards a better understanding of the structural diversity of proteins. Nucleic Acids Research, 48(W1), W60–W64. https://doi.org/10.1093/nar/gkaa443
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3–26.
  • Lönnroth, K., & Raviglione, M. (2016). The WHO’s new End TB strategy in the post-2015 era of the sustainable development goals. Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(3), 148–150. https://doi.org/10.1093/trstmh/trv108
  • Madeira, F., & Park, Y. (2019). The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Research, 47, 636–641.
  • Manallack, D. T. (2007). The p K a distribution of drugs : Application to drug discovery. Perspectives in Medicinal Chemistry, 1, 1177391X0700100. https://doi.org/10.1177/1177391X0700100003
  • Matteelli, A. (2018). Tuberculosis elimination: Where are we now? European Respiratory Review, 27(180035), 1–15. https://doi.org/10.1183/16000617.0035-2018
  • Méndez‐Samperio, P. (2017). Diagnosis of tuberculosis in HIV co-infected individuals: Current status, challenges and opportunities for the future. Scandinavian Journal of Immunology, 86(2), 76–82. https://doi.org/10.1111/sji.12567
  • Miotto, P., Zhang, Y., Cirillo, D. M., & Yam, W. C. (2018). Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Asian Pacific Social Respirol, 23, 1098–1113.
  • Oprea, T. I., Chemistry, M., Ab, A. H., & Mölndal, S. (2000). Property distribution of drug-related chemical databases. Journal of Computer-Aided Molecular Design, 14(3), 251–264. https://doi.org/10.1023/a:1008130001697
  • Öztürk, M., Tel-Çayan, G., Muhammad, A., & Duru, M. E. (2015). Mushrooms : A source of exciting bioactive compounds. Studies in Natural Products Chemistry, 45, 363–456.
  • Park, S. W. (2016). Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis. Chem Biol, 22(1), 76–86.
  • Perri, G., Gouy, M., De Biomdtrie, L., & Lyon-L, U. C. (1996). WWW-Query : An on-line retrieval system for biological sequence banks. Biochimie, 78(5), 364–369. https://doi.org/10.1016/0300-9084(96)84768-7
  • Pontius, J., Richelle, J., & Wodak, S. J. (1996). Deviations from standard atomic volumes as a quality measure for protein crystal structures. Journal of Molecular Biology, 264(1), 121–136. https://doi.org/10.1006/jmbi.1996.0628
  • Ren, L., Hemar, Y., Perera, C. O., Lewis, G., Krissansen, G. W., & Buchanan, P. K. (2014). Antibacterial and antioxidant activities of aqueous extracts of eight edible mushrooms. Bioactive Carbohydrates and Dietary Fibre, 3(2), 41–51.
  • Reynaud, Y., & Rastogi, N. (2016). New Mycobacterium tuberculosis LAM sublineage with geographical specificity for the Old World revealed by phylogenetical and Bayesian analyses. Tuberculosis, 101, 62–66. https://doi.org/10.1016/j.tube.2016.07.014
  • Roland Luthy, D. E., & Bowie, J. U. (1992). Assessment of protein models with three-dimensional profiles. Letters to the National, 356, 83–85.
  • Roy, A., Kucukural, A., & Zhang, Y. (2010). I-TASSER : A unified platform for automated protein structure and function prediction. Nature Protocols, 5(4), 725–738. https://doi.org/10.1038/nprot.2010.5
  • Sadowski, J., Gasteiger, J., Erlangen, D., & Klebe, G. (1994). Comparison of automatic three-dimensional model builders using 639 X-ray structures. Journal for Chemical Information and Computer scientists, 34(4), 1000–1008.
  • Salaemae, W., Azhar, A., Booker, G. W., & Polyak, S. W. (2011). Biotin biosynthesis in Mycobacterium tuberculosis : Physiology, biochemistry and molecular intervention. Protein & Cell, 2(9), 691–695. https://doi.org/10.1007/s13238-011-1100-8
  • Salaemae, W., Booker, G. W., & Polyak, S. W. (2016). The role of biotin in bacterial physiology and virulence : A novel antibiotic target for Mycobacterium tuberculosis. Microbiology Spectrum, 4(2), 1–20. https://doi.org/10.1128/microbiolspec.VMBF-0008-2015
  • Sánchez, C. (2010). Cultivation of Pleurotus ostreatus and other edible mushrooms. Applied Microbiology and Biotechnology, 85(5), 1321–1337. https://doi.org/10.1007/s00253-009-2343-7
  • Schrager, L. K., Harris, R. C., Vekemans, J., & Zenteno-Cuevas, R. (2018). Research and development of new tuberculosis vaccines : A review. F1000Research, 7, 1732. https://doi.org/10.12688/f1000research.16521.2
  • Schwab, C. H. (2010). 3D pharmacophore elucidation and virtual screening conformations and 3D pharmacophore searching. Drug Discovery Today: Technologies, 7(4), 245–253.
  • Shaaban, S., Negm, A., Sobh, M. A., & Wessjohann, L. A. (2015). Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry, 97, 190–201. https://doi.org/10.1016/j.ejmech.2015.05.002
  • Skariyachan, S., Prasanna, A., Manjunath, S. P., Karanth, S. S., & Nazre, A. (2016). Exploring the medicinal potential of the fruit bodies of oyster mushroom, Pleurotus ostreatus (Agaricomycetes), against multidrug-resistant bacterial isolates. International Journal of Medicinal Mushrooms, 18(3), 245–252. https://doi.org/10.1615/IntJMedMushrooms.v18.i3.70
  • Szklarczyk, D., et al. (2019). STRING v11 : Protein – protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47, 607–613.
  • T. U. Consortium. (2019). UniProt : A worldwide hub of protein knowledge. Nucleic Acids Research, 47, 506–515. https://doi.org/10.1093/nar/gky1049
  • Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999). The design of leadlike combinatorial libraries. Angewandte Chemie International Edition, 2, 3743–3748.
  • Turner, J., & Torrelles, J. B. (2018). Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. Pathogens and Disease, 76, 1–15.
  • Veber, D. F., Johnson, S. R., Cheng, H., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
  • Workneh, M. H., Bjune, G. A., & Yimer, S. A. (2017). Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity : A systematic review. PLoS One, 12(4), e0175925. https://doi.org/10.1371/journal.pone.0175925
  • Xu, D., & Zhang, Y. (2011). Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophysical Journal, 101(10), 2525–2534. https://doi.org/10.1016/j.bpj.2011.10.024
  • Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2015). The I-TASSER suite : Protein structure and function prediction. Nature Methods, 12(1), 7–8.
  • Zempleni, J., Wijeratne, S. S. K., Hassan, Y. I., & Sciences, H. (2008). Biotin. BioFactors (Oxford, England), 35(1), 36–46. https://doi.org/10.1002/biof.8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.